Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospitals Cleveland Medical Center
With
Repligen Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Patients 18 or above will be included in the study.
2. Patients suspected of pancreatic mass or with a known pancreatic mass would be enrolled in the study.
3. Patients with suspected pancreatic pathology and scheduled for imaging study (CT vs. MRI) will be included if they had obstructive jaundice, with either a stricture in the lower common bile duct on magnetic resonance cholangiopancreatography (MRCP) or a pancreatic mass on ultrasound or other imaging study.
You may not be if
1. Patients with known advanced pancreatic tumors and those with previous pancreatic resection will be excluded.
2. Patients with renal insufficiency: increase Cr level or glomerular filteration rate (GFR) of less than 45 ml/min/1.73.
3. Patients who demonstrate increase in Cr level or patients with acute renal injury.
4. Claustrophobic or patients who are not able to tolerate MRI.
5. Patients with previous history of contrast allergies.
6. Pregnant patients
Clareo Health | Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
